Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Tango Therapeutics Inc TNGX

Healthcare Biotechnology
Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors, including TNG462, which is in Phase 1/2 clinical trial for treating pancreatic and lung cancer; and TNG456, a brain... see more

Current News (NDAQ:TNGX)

Tango Therapeutics Announces CEO Transition: Barbara Weber to Retire, Malte Peters Appointed Successor

GlobeNewswire 10 days ago

Tango Therapeutics Appoints Sung Lee to Board of Directors

GlobeNewswire 13 days ago

Tango Therapeutics to Participate in 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire December 17, 2025

Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance

PR Newswire December 12, 2025

Tango Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference

GlobeNewswire November 26, 2025

Tango Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference

GlobeNewswire November 12, 2025

Tango Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights

GlobeNewswire November 4, 2025

Tango Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025

GlobeNewswire October 29, 2025

Tango Therapeutics Announces $225 Million Financing

GlobeNewswire October 23, 2025
View More News ››

Opinion & Analysis (NDAQ:TNGX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:TNGX)

Using technical analysis for this stock.

It is starting a big uptrend for shareholders today,so good luck to all of you
coolfooldumbguy - October 23, 2025

Tango Therapeutics, Inc. (TNGX): Pioneering Precision Oncolo

http://beyondspx.com/2024/08/02/tango-therapeutics-inc-tngx-pioneering-precision-oncology-with-promising-pipeline-and-robust-financials/
MikeTester - August 3, 2024
View more Bullboard ››

Lipari Mining Ltd.

Lipari Mining Ltd.

Lipari Mining is a natural diamond producer from its 100% owned Braúna diamond mine in Brazil. The Braúna mine is the only ...
View More »

Podcasts